I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Synthetic Lethality Screening Identifies FDA-Approved Drugs..:
Marta Mariniello
;
Raffaella Petruzzelli
;
Luca G. Wanderlingh
...
https://www.mdpi.com/2072-6694/12/3/608. , 2020
Link:
https://doi.org/10.3390/cancers12030608
RT Journal T1
Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:5c5d6e12cd354a5ba3e2a60e559951e2&Exemplar=1&LAN=DE A1 Marta Mariniello A1 Raffaella Petruzzelli A1 Luca G. Wanderlingh A1 Raffaele La Montagna A1 Annamaria Carissimo A1 Francesca Pane A1 Angela Amoresano A1 Ekaterina Y. Ilyechova A1 Michael M. Galagudza A1 Federico Catalano A1 Roberta Crispino A1 Ludmila V. Puchkova A1 Diego L. Medina A1 Roman S. Polishchuk PB MDPI AG YR 2020 K1 cancer K1 cisplatin resistance K1 atp7b K1 copper transporters K1 synthetic lethality screening K1 fda-approved drugs K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/12/3/608 LK http://dx.doi.org/https://doi.org/10.3390/cancers12030608 DO https://doi.org/10.3390/cancers12030608 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)